29 NHS hospital trusts dispute active use of Palantir platform
Prepared by Sintelligent with the help of SI. Published in SI: . Updated: .
The value of a large SI contract cannot be measured by the number of formally connected organizations: data submission, genuine daily use and proven patient benefit must be distinguished.
The Guardian and Medact sent more than 100 freedom-of-information requests. All 29 trusts that NHS England publicly listed as benefiting from the £330 million Federated Data Platform replied that the system was not live or that they were not using its applications. The Office for Statistics Regulation has taken the NHS claims into its casework process. NHS England maintains that nearly 140 trusts reported benefits from the tools and explains that the list includes back-office analytics and data submission, not only patient care. Infrastructure for data submission can count as live without operational use of the applications. Palantir cites 117,000 additional operations, a 14.3% reduction in discharge delays for long-stay patients and a 5.6% improvement in 28-day cancer diagnosis. NHS previously acknowledged that it could not prove a causal link between the platform and additional operations.
Sources 1